Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis
Clinical trial NCT04331795 · COMPLETED
Trial details
- NCT number
- NCT04331795
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-04
- Primary completion
- 2020-06-05
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.